Trial Profile
Acute heart failure in acute coronary syndrome: Double blind comparison of levosimendan and placebo
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Jul 2011
Price :
$35
*
At a glance
- Drugs Levosimendan (Primary)
- Indications Acute coronary syndromes; Decompensated heart failure; Myocardial infarction; Unstable angina pectoris
- Focus Therapeutic Use
- Acronyms LEVI'S
- 07 Jul 2011 New trial record